Neurotech International Limited (ASX:NTI)

Brian Leedman
Chairman
Market Cap (AUD): 40.47M
Sector: Health Care
Last Trade (AUD): 0.058 +0 (+0%)
Tab Bar

1. About

Neurotech International Limited (ASX:NTI) is a medical device and solutions company conducting clinical studies to assess the neuro-protective, anti-inflammatory and neuro-modulatory activities of our proprietary NTI/Dolce cannabis strains. 

Neurotech is also commercialising Mente, the world's first home therapy that is clinically proven to increase engagement and improve relaxation in autistic children with elevated Delta band brain activity.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk